Founded in 2008, the company's experienced team has a successful track record of developing new drug products that improve patients' lives. Elevation Pharmaceuticals has a disciplined approach to strategic decision-making and executes drug development plans with passion, integrity, and urgency. Their focus is on the development of aerosol therapies for patients with respiratory diseases, with the goal of meeting the needs and expectations of their stakeholders, including employees, investors, partners, and patients.